1月 2026
- 首頁
- PCI Synthesis
1月 2026PCI Synthesis的市場佔有率分析
we are full-service cgmp active pharmaceutical ingredients (api) contract manufacturing company of nce & drug products
PCI Synthesis(包含公司地區)
查看更多網站流量與參與度資訊- pcisynthesis.com
PCI Synthesis截至 1月 2026 的總收入為 25M - 50M
PCI Synthesis 熱門網域產生的總收入
PCI Synthesis 熱門網域 3 年內的總收入
PCI Synthesis 熱門網域的總收入
PCI Synthesis的熱門網域總造訪量
了解PCI Synthesis市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
無可顯示數據
無可顯示數據
PCI Synthesis的熱門網域平均造訪時長
分析PCI Synthesis參與度指標。
過去 3 個月平均造訪時長
無可顯示數據
無可顯示數據
PCI Synthesis的熱門網域平均頁面瀏覽量
了解PCI Synthesis如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
無可顯示數據
無可顯示數據
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自PCI Synthesis
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Pcisynthesis hired Bob Huang as Managing Director for North America on Sep 14th '21.Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs) and other specialty chemical products, today announced that Bob Huang has joined as Managing Director for North America.
9月 14, 2021閱讀更多
新聞Pcisynthesis hired Jean-Noel David as Managing Director for North America on Sep 15th '20.Newburyport, MA & Ecully, FRANCE, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Seqens CDMO North America (formerly known as PCI Synthesis, Inc.), a pharmaceutical manufacturer of new chemical entities (NCEs), active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that it has appointed Jean-Noel David as Managing Director for North America.
9月 15, 2020閱讀更多
新聞Pcisynthesis receives award awards in each of the six major award categories.Although PolyCarbon Industries, Inc. won awards in each of the six major award categories, and in addition received six other awards in specialty categories, PolyCarbon Industries, Inc. consider Reliability to be the among the most vital to sponsors.
8月 3, 2019閱讀更多
查看所有PCI Synthesis信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。